Leerink Partnrs Analysts Cut Earnings Estimates for Enhabit

Enhabit, Inc. (NYSE:EHAB - Free Report) - Equities researchers at Leerink Partnrs cut their FY2024 EPS estimates for shares of Enhabit in a research note issued to investors on Monday, November 18th. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings of $0.24 per share for the year, down from their prior forecast of $0.27. The consensus estimate for Enhabit's current full-year earnings is $0.25 per share. Leerink Partnrs also issued estimates for Enhabit's Q4 2024 earnings at $0.07 EPS, Q1 2025 earnings at $0.06 EPS, Q2 2025 earnings at $0.06 EPS, Q3 2025 earnings at $0.03 EPS, FY2025 earnings at $0.23 EPS, FY2026 earnings at $0.27 EPS and FY2027 earnings at $0.15 EPS.

Separately, Leerink Partners reiterated a "market perform" rating and set a $8.00 price objective (down from $8.50) on shares of Enhabit in a report on Tuesday. One research analyst has rated the stock with a sell rating and six have issued a hold rating to the stock. According to MarketBeat, Enhabit presently has an average rating of "Hold" and an average target price of $9.25.

Enhabit Stock Performance

NYSE EHAB opened at $7.46 on Thursday. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.46 and a quick ratio of 1.46. The company has a fifty day simple moving average of $7.52 and a 200 day simple moving average of $8.42. Enhabit has a 12-month low of $6.85 and a 12-month high of $11.74.

Enhabit (NYSE:EHAB - Get Free Report) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, missing analysts' consensus estimates of $0.04 by ($0.01). Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. The firm had revenue of $253.60 million during the quarter, compared to analyst estimates of $261.69 million. During the same period last year, the business posted $0.03 EPS.

Institutional Investors Weigh In On Enhabit

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. AREX Capital Management LP grew its stake in shares of Enhabit by 2.5% in the 2nd quarter. AREX Capital Management LP now owns 2,472,662 shares of the company's stock worth $22,056,000 after acquiring an additional 59,353 shares in the last quarter. Systematic Financial Management LP grew its position in Enhabit by 12.2% in the 3rd quarter. Systematic Financial Management LP now owns 1,838,199 shares of the company's stock worth $14,522,000 after purchasing an additional 199,235 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in Enhabit by 1.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,756,745 shares of the company's stock valued at $15,669,000 after buying an additional 26,753 shares during the last quarter. Paradice Investment Management LLC lifted its position in shares of Enhabit by 0.7% during the 2nd quarter. Paradice Investment Management LLC now owns 1,525,037 shares of the company's stock worth $13,603,000 after buying an additional 11,128 shares in the last quarter. Finally, Geode Capital Management LLC lifted its position in shares of Enhabit by 0.9% during the 3rd quarter. Geode Capital Management LLC now owns 1,137,458 shares of the company's stock worth $8,987,000 after buying an additional 10,538 shares in the last quarter.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.